Long-Term Safety of Febuxostat in Subjects With Gout.

PHASE2CompletedINTERVENTIONAL

Enrollment

116

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

Gout

Interventions

DRUG

Febuxostat

Febuxostat 40 mg, tablets, orally, once daily, based on serum urate level.

DRUG

Febuxostat

Febuxostat 80 mg, tablets, orally, once daily, based on serum urate level.

DRUG

Febuxostat

Febuxostat 120 mg, tablets, orally, once daily, based on serum urate level.